2016 International Congress Archives - Page 118 of 207

Lysosomal alterations in peripheral blood mononuclear cells of Parkinson’s disease patients

N. Papagiannakis, M. Xilouri, C. Koros, M. Stamelou, R. Antonelou, M. Maniati, D. Papadimitriou, M. Moraitou, H. Michelakakis, L. Stefanis (Chaidari, Greece)
Magnetic resonance characteristic of Parkinson’s disease based on the presence of cognitive impairment

F.B. Doniyorova (Tashkent, Uzbekistan)
Magnetic resonance diffusion tensor imaging for the pedunculopontine nucleus: Correlation between neuroimaging and cytoarchitectonic features

A.T.D.L. Alho, C. Hamani, E.J.L. Alho, R.E. da Silva, G.A.B. dos Santos, R.C. Neves, C.M.M. Araujo, G. Magalhães, L.T. Grinberg, H. Heinsen, E.T. Fonoff, E. Amaro-Junior (São Paulo, Brazil)
Magnetic resonance imaging and pyramidal impairment in Huntington disease

A. Sanguinetti, S. Lescano, M. Cesarini, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)
Magnetic resonance imaging in spinocerebellar ataxias: A systematic review

J.A. Saute, E. Reckziegel, M.C. França Jr, T.J.R. Ribeiro, L.M. Vedolin, L.B. Jardim, A.A. Klaes (Porto Alegre, Brazil)
Magnetic resonance imaging of nigrosome-1 in the diagnosis of early Parkinson’s: Initial results of the Parkinson’s magnetic imaging repository (PaMIR)

S.T. Schwarz, Y. Xing, A. Martin Bastida, C. Lakmali Sugathapala, M. Silverdale, J. Mclean, R. Jampana, N. Bajaj, D. Burn, P. Piccini, D. Grosset, D.P. Auer (Nottingham, United Kingdom)
Maintenance of balance function in patients with HD treated with deutetrabenazine, as measured by Berg balance test (BBT) in First-HD

D.O. Claassen, D. Oakes, D. Stamler, V. Sung, C.M. Testa, S. Frank, On behalf of the First-HD HSG Investigators (Nashville, TN, USA)
Manganese-induced parkinsonism and motor neuron damage- Can there be a relationship?

I. Giorgishvili, N. Lobjanidze, N. Akiashvili, M. Janelidze, M. Beridze (Tbilisi, Georgia)
Manual MRI morphometry in Parkinsonian syndromes

L. Möller, J. Kassubek, M. Südmeyer, R. Hilker, E. Hattingen, K. Egger, F. Amtage, G. Respondek, M. Stamelou, A. Schnitzler, W.H. Oertel, S. Knake, H.J. Huppertz, G.U. Höglinger (Marburg, Germany)
May early introduction of dopaminergic agonists improve simptoms after ischemic stroke? The interim report

J. Kobal, Z. Melik, K. Cankar (Ljubljana, Slovenia)